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Abstract
Background: Symptomatic infection by dengue virus (DENV) can range from dengue fever (DF) to dengue haemorrhagic
fever (DHF), however, the determinants of DF or DHF progression are not completely understood. It is hypothesised that
host innate immune response factors are involved in modulating the disease outcome and the expression levels of genes
involved in this response could be used as early prognostic markers for disease severity.
Methodology/Principal Findings: mRNA expression levels of genes involved in DENV innate immune responses were
measured using quantitative real time PCR (qPCR). Here, we present a novel application of the support vector machines
(SVM) algorithm to analyze the expression pattern of 12 genes in peripheral blood mononuclear cells (PBMCs) of 28 dengue
patients (13 DHF and 15 DF) during acute viral infection. The SVM model was trained using gene expression data of these
genes and achieved the highest accuracy of ,85% with leave-one-out cross-validation. Through selective removal of gene
expression data from the SVM model, we have identified seven genes (MYD88, TLR7, TLR3, MDA5, IRF3, IFN-a and CLEC5A)
that may be central in differentiating DF patients from DHF, with MYD88 and TLR7 observed to be the most important.
Though the individual removal of expression data of five other genes had no impact on the overall accuracy, a significant
combined role was observed when the SVM model of the two main genes (MYD88 and TLR7) was re-trained to include the
five genes, increasing the overall accuracy to ,96%.
Conclusions/Significance: Here, we present a novel use of the SVM algorithm to classify DF and DHF patients, as well as to
elucidate the significance of the various genes involved. It was observed that seven genes are critical in classifying DF and
DHF patients: TLR3, MDA5, IRF3, IFN-a, CLEC5A, and the two most important MYD88 and TLR7. While these preliminary
results are promising, further experimental investigation is necessary to validate their specific roles in dengue disease.
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Introduction
Dengue virus (DENV) is an emerging mosquito-borne pathogen
that infects approximately 50–100 million people every year. The
virus has an RNA genome and exists as four major serotypes
(DENV1-4) that are phylogenetically distinct [1]. According to the
World Health Organization (WHO) reports during the past 50
years, the incidence of dengue has increased 30-fold and it is
estimated that 2.5 billion people live in endemic areas spread over
100 countries [2]. Symptomatic infection by DENV can range
from a mild disease, dengue fever (DF), to a severe dengue
haemorrhagic fever (DHF), which can culminate with dengue
shock syndrome (DSS) and death. Although sequential dengue
infection by distinct serotypes and antibody-mediated enhance-
ment (ADE) are the two most studied risk factors for the
development of the severe diseases, the key determinants of DF
or DHF progression remain elusive [2–6].
During infection, the innate immune response plays an
important role as the first line of defence and also in the shaping
of the adaptive responses. One of the first steps of the innate
responses is the recognition of pathogen-associated molecular
patterns (PAMPs) [7]. The innate immune system identifies these
patterns through pattern recognition receptors (PRRs) [8], such as
the Toll-like receptors (TLRs) 3, 7, and 9 located at the cellular
membranes, and also by cytoplasmic proteins, like the retinoic
acid-inducible gene-I (RIGI) and melanoma differentiation-
associated gene 5 (MDA5). Binding of viral molecules to these
PRRs results in a downstream activation of a gene cascade,
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includingMYD88 (an adapter protein that serves as an intermediate
molecule), transcriptions factors (IRF3 and IRF7), and the
expression of interferon (IFN) type I and II genes [7]. IFNs are
produced by many types of cells and induce an antiviral state by up-
regulating genes with direct and indirect antiviral functions [7–15].
While it is known that IFNs are the first line in the host defence
against DENV infections [7], and that DENV inhibits the IFN
signalling pathway [16], the actual relationship between the ability
to block IFN signal and pathogenicity is not known. We previously
postulated that the expression levels of the TLRs and the signal
transduction molecules of IFN type I and II pathway would have a
significant role in modulating the host IFN response to DENV and
hence the disease outcome. The possible associations of this
interplay with clinical outcomes appear complex, with indications
that differential expression of different immunological pathways
result in disparate clinical outcomes [17]. To investigate the possible
role of the expression level of these genes at mRNA levels during
DENV infection, it is necessary to design rational gene expression
studies followed by careful analyses of gene expression patterns in
well characterized dengue patients [18]. Towards this end, several
groups have been studying disease susceptibility factors, via high
throughput molecular typing or through association studies to
identify disease associated candidate genes [2]. In silico approaches
utilizing clinical data have been developed to improve dengue
diagnosis and prognosis. Recently, our group developed a simple
method to reliably differentiate primary and secondary acute
dengue infections based on serological data (IgG ELISA) [19] and
quickly identify individuals with a secondary dengue infection,
which is considered as a risk factor. Nevertheless, only a small
fraction of secondary infections develop DHF and the early
detection of patients with risk of developing DHF is still not possible.
In this manuscript, we present a computational approach to
classify DF and DHF patients based on mRNA expression data of
11 genes (MYD88, MDA5, TLR3, TLR7, TLR9, IRF3, IRF7,
IFN-a, IFN-b, IFN-c, and RIGI) involved in the innate immune
response pathway using the support vector machines (SVM)
algorithm. The significance of these genes in determining DF or
DHF progression was also explored using this approach.
Additionally, CLEC5A, a cell surface receptor, which is also
involved in innate response, was included in the analysis as a
reference marker because it has been proposed to be involved in
the development of DHF [20]. A schematic map depicting the
interactions of the 12 proteins/genes in the viral innate immune
response pathway is provided in Figure 1. We selected these genes
because i) they have been previously shown to have a significant
fold-change in our cDNA microarray analysis [18] of genes
expressed in patients with DF versus DHF, compared to non-
dengue (ND) patients, or ii) they have been described to be
relevant for hemorrhagic symptoms of dengue by others in the
literature [7–10,12,17,20]. The aim of this study was to help
identify important genes or pathways of the innate immune
responses involved in DF or DHF, which can then be used as
markers.
SVM, introduced by Cortes and Vapnik [21], is a relatively new
sub-branch of supervised learning methods, and has been shown
to be highly effective for diverse computational biology applica-
tions [22]. Some example applications include prediction of
secondary structure, quaternary structure, homology, domains,
cleavage sites, protein-protein interaction, T-cell epitopes, classi-
fication and validation of cancer tissue samples and also
microarray expression data. Our gene expression data from
dengue disease patients provides an opportunity to better
Figure 1. A schematic map depicting the interactions of the 12 proteins/genes studied herein, known or indicated to be relevant to
the viral innate immune response pathway, including for dengue.
doi:10.1371/journal.pone.0011267.g001
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understand the relevance of the individual genes in the DENV
infection pathway involving the innate immune response. Though
the application of SVM as a classification tool for expression data
is not new, its utility to analyse the role of genes of the innate
immune response pathway in DENV has not been explored.
Materials and Methods
Ethics statement
All participants signed an informed consent. This study, related
to gene expression of dengue patients and application of the SVM
algorithm to the data is part of a bigger functional immunomics
study in our lab and was reviewed and approved by ethics
committee of Brazilian Ministry of Health CONEP: 4909; Process
nu 25000.119007/2002-03; CEP: 32/09. In addition, the Johns
Hopkins IRB also reviewed this study as protocol JHM-IRB-3: 03-
08-27-01.
Patient data
A total of 33 patients (5 ND, 15 DF and 13 DHF) were studied
from the Recife metropolitan area, Brazil [23] and were classified
following the WHO criteria [4]. Blood samples from patients
enrolled in this study were collected in heparin vacutainer tubes
(BD Vacutainer) and within 2 hours after the collection, peripheral
blood mononuclear cell (PBMC) samples were separated by
gradient density using Ficoll-Paque (Amersham Biosciences) and
cryopreserved in 10% (v/v) Dimethyl sulfoxide (DMSO; Sigma-
Aldrich) in inactivated fetal bovine sera (FBS; Hyclone). All
samples were collected from patients between 3rd and the 5th day
of onset of fever.
Gene expression
RNA extraction was performed according to the manufacturer’s
manual for the Spin cell RNA mini kit (Invisorb). Total RNA was
reverse transcribed to cDNA using SuperScript III First-strand
Synthesis System for qPCR (Invitrogen) using random hexamer
primers, according to the manufacturer’s instructions. The
expression of 12 genes related to viral innate immune response
were quantified using qPCR based on 2‘-DDCt method [24].
Expression values for each gene were normalized by use of beta-
actin housekeeping gene, which were then quantified and related
to ND cycle threshold (Ct) values (i.e. DF/ND ratio).
For each of the 12 genes tested, the DF/ND and DHF/ND
ratio of qPCR experimental values were used to define the up-
regulated and down-regulated states of the genes (Figure 2). DF/
ND and DHF/ND ratio values of .=1 were defined as up-
regulated, while DF/ND and DHF/ND values of ,1 were
defined as down-regulated.
Statistical analysis
Statistical analyses were performed on qPCR data using
unpaired two-tailed Student’s T test with Welch’s correction due
to the small sample size and because we assumed unequal
variances in the data. All tests were done using the Prism software
version 4.0a (www.graphpad.com).
SVM implementation
The SVM algorithm is a machine learning technique developed
based on the structural risk minimization principle of statistical
learning theory (see [25] for details on the algorithm and [22] for
details on its implementation, optimization, training and testing).
Figure 2. Heatmap for gene expression data of the 12 genes (columns) studied from the 28 patients (rows). The first 15 are DF patients,
while the rest are DHF patients. The DF/ND and DHF/ND gene expression values from qPCR were used to create the heatmap. The colour shades are
associated with the values in the cells: green for ratio of DF/ND and DHF/ND of ,1 (down-regulated) and red for DF/ND and DHF/ND ratio of .= 1
(up-regulated). The gene expression data for IFN-b of one of the patients (23) was not available and therefore the vector attributes of this gene for
the patient were represented as blank.
doi:10.1371/journal.pone.0011267.g002
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Briefly, both positive and negative examples in a dataset were
represented by feature vectors xi (i=1, 2,…, N) with corresponding
binary labels yi [ z1,{1gf . The SVM algorithm classifies the
positive and negative examples by training a classifier which maps
the input samples, using a kernel function in most cases, onto a
high-dimensional space, and then seeks for a separating hyper-
plane that best differentiates the two classes with a maximal
margin and a minimal error. The decision function for
classification of unseen examples is given as:
f (x)~sgn(
Xm
i~1
aiyi:k(x,xi)zb)
where K xi : xj
 
is the kernel function, and the parameters are
determined by maximizing the following:
XN
i~1
ai{
1
2
XN
i~1
XN
j~1
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XN
i~1
aiyi~0 and 0ƒaiƒC
The variable C serves as the cost parameter that controls the trade-
off between margin and classification error. As the efficacy of the
SVM-based classification is dependent on the type of kernel used,
we explored the use of various commonly used kernels (linear,
sigmoid, polynomial and the radial basis function) on our datasets.
We chose the radial basis function (RBF) kernel as it was found to
be most effective (data not shown):
K(xi,xj)~ exp
{ xi{xj
 2
2c2
 !
Two parameters are required to optimize the RBF kernel of the
SVM classifier; c, which determines the capacity of the RBF
kernel and C, the regularization parameter.
Vector encoding schemes
To encapsulate gene expression data in a format suitable for SVM
training and testing, vectors based on the orthonormal encoding
scheme were created. Each gene was designated as either ‘‘10’’ (for
observation of up-regulation) or ‘‘01’’ (for observation of down-
regulation). Therefore, the collective gene expressions observed in
each patient was represented by a 24-dimension vector (12 genes62
gene states: up- or down-regulated). Each of the 24-dimension vectors
was labeled as either ‘‘1’’ for DF patients or ‘‘21’’ for DHF patients,
corresponding to positive and negative examples for SVM training,
respectively. The first 15 rows in the input matrix corresponded to the
gene expression data of the 15 DF patients analyzed herein, while the
last 13 rows were of the DHF patients. The vector labels ‘‘1’’ and
‘‘21’’ are in the first column of the matrix and the subsequent 12
columns of each row correspond to the gene expression states, in
orthonormal encoding scheme, for the 12 genes studied. For
example, the vector encoding ‘‘1 1:1 4:1…’’ represents data of a
DF patient (1, first column) and the first two genes, TLR3 and TLR7,
which are up-regulated and down-regulated, respectively.
It is noted that the gene expression data for IFN-b of one of the
patients (23) was not available and therefore the vector attributes
of this gene for the patient were represented as blank, and this
notation was acceptable as our simulation studies of setting the
gene as up- or down-regulated did not change the accuracy of the
model.
SVM model development
The SVM model was implemented using the freely download-
able LIBSVM package by Chang and Lin [26]. Here, the SVM
model was used to classify the DF and DHF patients using gene
expression data from the patients. We conducted leave-one-out
cross-validation (LOOCV) on the patient gene expression dataset
using various combinations of c and C. In LOOCV, the patient
vectors dataset was split into 28 training examples where one of
the training examples was used as the test example while the others
were used for training the SVM classifier. The trained classifier
was tested on the test example. The process was repeated 28 times
using different test and training examples each time, hence
ensuring that all examples were included for both training and
testing. SVM parameters c and C were stepped through
combinations of 0.01, 0.1, 1, 10, and 100 for C, and 0.1, 1, 10,
100, and 1000 for c in a grid-based manner. To provide an
indication of the overall performance of the model, the accuracy
(AC), as given in the following equation, was calculated on the
output of the LOOCV:
AC %ð Þ~ TPzTN
TPzFNzTNzFP
|100
The values of C and c that returned the optimal accuracy were
noted. The corresponding accuracy value obtained was assigned as
baseline.
The cross-validation procedure was repeated fifteen times under
different conditions to analyse the individual and collective
contributions of each gene expression data to DF/DHF classifi-
cation. Specifically, in the first twelve trials, a different gene was
removed from the vector dataset, while multiple genes were
removed from the vector dataset in the last three trials.
Corresponding changes to the baseline accuracy were measured
for all cases (Table 1).
Results
A total of 12 genes (TLR3, TLR7, TLR9, RIGI, IRF3, IRF7,
MYD88, CLEC5A, IFN-a, IFN-c, IFN-b, and MDA5), were
quantified in 28 dengue patients (13 DHF and 15 DF) using
qPCR. The expression data was obtained from PBMCs of patients
with DF and DHF during acute phase (between 3rd and 5th day of
fever) before defervescence and any signs of vascular leakage. The
gene expression data was used to explore associations of individual
expression levels with DF and DHF using the SVM algorithm. We
had selected the RBF kernel because it was shown to perform well
on our datasets and it is also widely used for SVM classification in
other related domains. The parameters (C and c) of RBF were
optimized by performing leave-one-out cross validation. The C
and c values that returned the highest accuracy of ,85.18% were
C of 1, 10 (selected for further work) or 100 and c of 1.0 (Figure 3).
Henceforth, this accuracy of ,85.18% will be referred to as the
baseline accuracy for the SVM model of the 12 genes.
Influence of each gene to the accuracy of the SVM model
To define the contribution of each of the 12 genes on the
determination of DF and DHF, selective removal of vector
attributes corresponding to each specific gene expression data
were carried out and the downstream effect on the baseline
SVM Model for Dengue Patients
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accuracy of the SVM model were measured. Vector attributes of
genes removed from the input vectors that result in a significant
reduction in the model accuracy are likely to be more relevant to
determine the differences between the DF and DHF gene
expression pattern. We postulated that genes with greater impact
on the model accuracy would have a relatively greater importance
defining the different innate immune response in DF and DHF
patients.
The genes MYD88, TLR7, TLR3, MDA5, IRF3, IFN-a and
CLEC5A were observed to be relevant in defining the distinction
between DF from DHF expression patterns, and among these
MYD88 and TLR7 were the two most important (Figure 4 and
Table 1). Removal of MYD88 or TLR7 decreased the baseline
accuracy to ,66.66% and ,81.48%, respectively. The individual
removal of the genes TLR3, MDA5, IRF3, IFN-a, and CLEC5A
from the input matrix dataset did not change the accuracy value
obtained with all the 12 genes (,85.18%). However, when these
five genes were trained collectively with MYD88 and TLR7, the
accuracy increased to ,96.26% (Figure 4 and Table 1), indicating
a subtle individual, but significant combined role of these five
genes. According to our SVM results, the remaining five genes
(TLR9, RIGI, IRF7, IFN-b and IFN-c) showed negative effect to
the classification of the patient types – individual removal of the
five genes increased the accuracy (,88.88 to ,92.59%; Figure 4
and Table 1), suggesting that in the context of the genes selected
and the disease outcome there is a lack of association between the
mRNA levels of these five genes with the levels of the others.
Taken together, the observations that the expression levels of
signal transduction molecules had important effect in the model
and the negative effects of IFN-b and IFN-c suggest that impaired
IFN signalling play important role in DHF.
Discussion
In this study, we describe application of the SVM algorithm to
classify DF and DHF patients based on the expression data of
innate immune response pathway genes, to better understand their
roles in the disease progression. SVM modelling of the expression
patterns of the 12 genes in the dengue patients with different
disease outcomes implicates the association of some of the genes
with the severity of dengue symptoms. Our results suggest that
MYD88 and TLR7 genes are relatively the most important for
defining specific DF and DHF expression patterns. This finding is
supported by experimental data that showed the utilization of the
TLR7 receptor by DENV [5] and the direct influence of the virus
on the expression of MYD88 [14]. In addition, it is clear from the
gene expression data that the expression levels of TLR7 and
MYD88 are significantly higher in DHF patients than in DF
Table 1. Performance of SVM model for various combinations of genes tested. RBF kernel function (c value = 1.0 and C value = 10)
was utilized for model building.
Matrix
conditions Genes tested Gene(s) removed Accuracy (%)
1 MYD88, MDA5, TLR7, TLR9, IRF3, IRF7, CLEC5A, IFN-a, IFN-b, IFN-c, and RIGI TLR3 85.19
2 MYD88, MDA5, TLR3, TLR9, IRF3, IRF7, CLEC5A, IFN-a, IFN-b, IFN-c, and RIGI TLR7 81.48
3 MYD88, MDA5, TLR3, TLR7, IRF3, IRF7, CLEC5A, IFN-a, IFN-b, IFN-c, and RIGI TLR9 92.59
4 MYD88, TLR3, TLR7, TLR9, IRF3, IRF7, CLEC5A, IFN-a, IFN-b, IFN-c, and RIGI MDA5 85.19
5 MDA5, TLR3, TLR7, TLR9, IRF3, IRF7, CLEC5A, IFN-a, IFN-b, IFN-c, and RIGI MYD88 66.66
6 MYD88, MDA5, TLR3, TLR7, TLR9, IRF3, IRF7, CLEC5A, IFN-a, IFN-b, and IFN-c RIGI 92.59
7 MYD88, MDA5, TLR3, TLR7, TLR9, IRF7, CLEC5A, IFN-a, IFN-b, IFN-c, and RIGI IRF3 85.18
8 MYD88, MDA5, TLR3, TLR7, TLR9, IRF3, CLEC5A, IFN-a, IFN-b, IFN-c, and RIGI IRF7 88.88
9 MYD88, MDA5, TLR3, TLR7, TLR9, IRF3, IRF7, CLEC5A, IFN-b, IFN-c, and RIGI IFN-a 85.18
10 MYD88, MDA5, TLR3, TLR7, TLR9, IRF3, IRF7, CLEC5A, IFN-a, IFN-c, and RIGI IFN-b 92.59
11 MYD88, MDA5, TLR3, TLR7, TLR9, IRF3, IRF7, CLEC5A, IFN-a, IFN-b, and RIGI IFN-c 88.88
12 MYD88, MDA5, TLR3, TLR7, TLR9, IRF3, IRF7, IFN-a, IFN-b, IFN-c, and RIGI CLEC5A 85.18
13 MYD88, MDA5, TLR3, TLR7, IRF3, CLEC5A, and IFN-a TLR9, RIGI, IRF7, IFN-b, and IFN-c 96.26
14 MDA5, TLR3, TLR9, IRF3, IRF7, CLEC5A, IFN-a, IFN-b, IFN-c, and RIGI TLR7 and MYD88 62.96
15 MYD88 and TLR7 TLR3, TLR9, MDA5, RIGI, IRF3, IRF7,
IFN-a, IFN-b, IFN-c, and CLEC5A
88.88
doi:10.1371/journal.pone.0011267.t001
Figure 3. SVM optimization. Optimization of the parameters C and c
of the SVM kernel RBF: only C values of 0.01, 0.10, 1.0, 10.0 and 100.0,
and c value of 1.0 are shown.
doi:10.1371/journal.pone.0011267.g003
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(Table 2). Based on these analyses, we posit that these two genes
and possibly others in the TLR7 pathway are likely to be good
candidates for further studies.
Apart from MYD88 and TLR7, five other genes (TLR3,
MDA5, IRF3, IFN-a, and CLEC5A) were observed to exhibit
subtle individual, but significant collective role (Table 1). The
significant involvement of the genes TLR3, IRF3 and MDA5 on
the diagnostic specific expression pattern suggests that DENV
likely interacts with more than one IFN activation pathway [7,14].
CLEC5A, a cell surface receptor, has been reported to be
differentially expressed between DF and DHF patients, suggesting
involvement in the development of DHF [20]. However, in our
study, the differences in mRNA expression levels of CLEC5A
between DF and DHF patients were relatively less relevant than
TLR7 and MYD88 (Table 2). This difference could be because of
the different experimental approaches utilized, whereby our data
was from clinical patients and theirs was an in vitro study. IFN-a,
the other member of the five genes, is a well-established antivirus
response factor and we observed over-expression for both DF and
DHF patients. The five genes (TLR9, RIGI, IRF7, IFN-b and
IFN-c) that showed negative effect on the accuracy confounded
the classification of DF and DHF patients. However, further
investigation is necessary before we can eliminate their specific role
in this regard. It is possible that the IFN-a is being produced but its
signal is not being efficiently transduced.
Two important limitations of the present study include the small
sample size of the patient data and the sampling bias. This may
impact the interpretation of our results, which were based only on
28 patients from Brazil. Nevertheless, despite these limitations, we
have shown the utility of the SVM method in deciphering the
complex interplay of numerous genes involved in a biological
pathway through gene expression data of patient samples.
Moreover, the method is scalable as new patient sample data can
be easily appended to the preliminary SVM model and reassessed.
In addition, several novel machine learning algorithms have been
reported by various groups to accurately select gene markers in
expression studies [27–29]. As they are particularly effective for
handling large datasets and feature dimensionality, it would be
useful to explore these methods for DF and DHF classification as
larger and more complex expression datasets become available.
Notably, the SVM model built on a large number of expression
data can potentially be used to accurately classify the prognosis of
patients with the benign form (DF) from those with the life-
threatening (DHF) DENV disease. The lack of reliable classifica-
tion tools to differentiate DF and DHF patients has often resulted
in a large number of unnecessary and costly hospitalizations
[6,19]. Further, early diagnosis of DHF patients will represent
better prognosis.
In summary, this is the first report of application of the SVM
method to gene expression data from DF and DHF patients to
better understand the role of the genes in DENV infection
pathway. The results suggest important role of seven genes in
classifying DF and DHF patients: TLR3, MDA5, IRF3, IFN-a,
CLEC5A, and the two most important MYD88 and TLR7.
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Figure 4. Influence of each gene to the accuracy of the baseline SVM model. The first bar represents the baseline accuracy of all the 12
genes (TLR3, TLR7, TLR9, MDA5, MYD88, RIGI, IRF3, IRF7, IFN-a, IFN-b, IFN-c, and CLEC5A). The subsequent bars represent accuracy of datasets with
only 11 genes, whereby vector attributes of one gene were removed at a time (the name of the gene removed is indicated). The last bar, SVM model
refers to the seven genes (MYD88, TLR3, TLR7, MDA5, IRF3, IFN-a and CLEC5A) that returned optimum accuracy. The RBF kernel function of SVM with
optimum parameter settings (C= 10 and c= 1.0) were used for model building of each situation. * represents p,0.05 value compared with the 12
baseline gene set (the bar labelled ‘‘All 12 genes’’).
doi:10.1371/journal.pone.0011267.g004
Table 2. Average gene expression ratios (DF/ND and DHF/
ND) for the seven genes found to be important for the
classification of DF and DHF patients.
Dengue
clinical form Genes
TLR7 MYD88 TLR3 MDA5 IRF3 IFN-a CLEC5A
DF/ND 01 01 01 10 01 10 01
DHF/ND 10 10 01 01 01 10 01
The binary ‘‘01’’ means ratio of DF/ND and DHF/ND of,1 (down-regulated) and
‘‘10’’ means DF/ND and DHF/ND ratio of .= 1 (up-regulated).
doi:10.1371/journal.pone.0011267.t002
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